Metabolic syndrome risks of cardiovascular disease: differences between HIV-positive and HIV-negative?
Metabolic syndrome risks of cardiovascular disease: differences between HIV-positive and HIV-negative?
复制标题
心血管疾病的代谢综合征风险：HIV 阳性和 HIV 阴性之间的差异？
DOI：
10.1111/j.1559-4572.2008.07592.x
复制
发表时间：
2008
期刊：
影响因子：
--
通讯作者：
Reeds,DominicN
中科院分区：
文献类型：
--
作者：
Reeds,DominicN
Highly active antiretroviral therapy (HAART) has markedly prolonged life expectancy in patients infected with the human immunodeficiency virus (HIV). Use of HAART has been associated with development of a metabolic syndrome that may increase the risk of developing ischemic heart disease. The purpose of this review is to discuss the incidence and clinical manifestations of the metabolic syndrome in patients with HIV infection and contributing factors, as well as whether cardiovascular risk is disproportionately elevated in patients with HIV‐associated metabolic syndrome.
